1 not yet recruiting, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow SYS6020 injection: new trials by email Literature Review of SYS6020 injection trials Research Report on SYS6020 injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis SYS6020 injection - Multiple Sclerosis | Phase 1 / Phase 2 | Not yet recruiting | Tongji Hospital | 25 | 2026-09-16 | 2026-08-10 |
| A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia Gravis SYS6020 injection - Myasthenia Gravis | Phase 1 | Recruiting | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 60 | 2025-03-04 | 2026-08-12 |
Multiple Sclerosis (1) · Multiple Sclerosis, Chronic Progressive (1) · Myasthenia Gravis (1)
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1) · Tongji Hospital (1)
China (2)
Chuan Qin, MD (1) · Daishi Tian, MD (1) · Zhouping Tang, MD (1)